Display options
Cite
Aljarrah Q, Bakkar S, Aleshawi A, et al. Analysis of the Peri-Operative Cost of Non-Traumatic Major Lower Extremity Amputation in Jordan. Clinicoecon Outcomes Res. 2020;12:13-21doi: 10.2147/CEOR.S232779.
Aljarrah, Q., Bakkar, S., Aleshawi, A., Al-Gharaibeh, O., Al-Jarrah, M., Ebwayne, R., Allouh, M., & Abou-Foul, A. K. (2020). Analysis of the Peri-Operative Cost of Non-Traumatic Major Lower Extremity Amputation in Jordan. ClinicoEconomics and outcomes research : CEOR, 1213-21. https://doi.org/10.2147/CEOR.S232779
Aljarrah, Qusai, et al. "Analysis of the Peri-Operative Cost of Non-Traumatic Major Lower Extremity Amputation in Jordan." ClinicoEconomics and outcomes research : CEOR vol. 12 (2020): 13-21. doi: https://doi.org/10.2147/CEOR.S232779
Aljarrah Q, Bakkar S, Aleshawi A, Al-Gharaibeh O, Al-Jarrah M, Ebwayne R, Allouh M, Abou-Foul AK. Analysis of the Peri-Operative Cost of Non-Traumatic Major Lower Extremity Amputation in Jordan. Clinicoecon Outcomes Res. 2020 Jan 09;12:13-21. doi: 10.2147/CEOR.S232779. eCollection 2020. PMID: 32021336; PMCID: PMC6966148.
Copy Download .nbib Format: NLM
Share it on

Clinicoecon Outcomes Res. 2020 Jan 09;12:13-21. doi: 10.2147/CEOR.S232779. eCollection 2020.

Analysis of the Peri-Operative Cost of Non-Traumatic Major Lower Extremity Amputation in Jordan.

ClinicoEconomics and outcomes research : CEOR

Qusai Aljarrah, Sohail Bakkar, Abdelwahab Aleshawi, Omar Al-Gharaibeh, Mooath Al-Jarrah, Radi Ebwayne, Mohammed Allouh, Ahmad K Abou-Foul

Affiliations

  1. Department of Surgery, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
  2. Department of Surgery, Faculty of Medicine, The Hashemite University, Zarqa 13133, Jordan.
  3. School of Medicine, Faculty of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
  4. Department of Anatomy, College of Medicine & Health Sciences, United Arab Emirates University, Al Ain 17666, United Arab Emirates.
  5. Department of Otolaryngology, Head and Neck Surgery, Imperial College Healthcare NHS Trust, St Mary's Hospital, London W2 1NY, UK.

PMID: 32021336 PMCID: PMC6966148 DOI: 10.2147/CEOR.S232779

Abstract

PURPOSE: Non-traumatic major lower extremity amputation (NMLEA) is a commonly performed procedure that presents a substantial cost burden. Patients who undergo NMLEA are usually considered as a high-risk group with significant comorbidities, which translates into a protracted peri-operative course and increased health-care costs. The primary aim of this study was therefore to perform a contemporary peri-operative cost analysis of NMLEA performed in our center. We are a major tertiary referral hospital that provides vascular surgery services to the entire northern counties in Jordan. We also aimed to assess the various factors that influence the cost of NMLEA in less economically developed countries.

METHODS: Records of all patients who underwent NMLEA at King Abdullah University Hospital between January 2012 and December 2017 were retrieved. Total inpatient cost was calculated and analyzed against different patients' variables.

RESULTS: A total of 140 patients underwent NMLEA between 2012 and 2017 in our facility. Below-knee amputations accounted for 110 cases, while above-knee amputations included 30 patients. Approximately two-thirds of the cases (61.4%) were males, with average age of the patients being approximately 62.9 years. The commonest comorbidities were diabetes mellitus and hypertension, which were recorded in 89.3% and 80.3% of the patients, respectively. The average operative time was 133.0 ± 10.8 mins, and the average length of stay (LOS) was 6.7±0.4 days. The mean cost for amputations was 4904.7± 429.3 United States dollars. Multiple linear regression analysis demonstrated that LOS and admission-to-operation time were the independent predictors of cost.

CONCLUSION: Delayed amputations and prolonged LOS remain the most important determinants for the peri-operative cost of NMLEA. When amputation is deemed inevitable, an expedited multidisciplinary approach may possibly reduce undue delays and result in cost-effective delivery of this age-old remedy.

© 2020 Aljarrah et al.

Keywords: amputation; diabetic foot syndrome; health care cost; ischemia; length of stay

Conflict of interest statement

The authors have no financial ties or conflicts of interest to disclose.

References

  1. Pharmacoeconomics. 2009;27(1):81-90 - PubMed
  2. Ann Vasc Surg. 2014 Jul;28(5):1149-56 - PubMed
  3. Diabetes Res Clin Pract. 2018 Apr;138:271-281 - PubMed
  4. Lancet. 2005 Nov 12;366(9498):1719-24 - PubMed
  5. Expert Rev Pharmacoecon Outcomes Res. 2003 Feb;3(1):25-32 - PubMed
  6. J Vasc Surg. 2016 Mar;63(3):696-701 - PubMed
  7. Arch Phys Med Rehabil. 2005 Mar;86(3):480-6 - PubMed
  8. J Vasc Surg. 2010 Sep;52(3 Suppl):17S-22S - PubMed
  9. Arch Surg. 2010 Dec;145(12):1201-8 - PubMed
  10. Am J Phys Med Rehabil. 2013 Mar;92(3):203-14 - PubMed
  11. Arch Phys Med Rehabil. 2008 Mar;89(3):422-9 - PubMed
  12. Prosthet Orthot Int. 2012 Dec;36(4):430-4 - PubMed
  13. Diabetologia. 2006 Nov;49(11):2634-41 - PubMed
  14. BMJ Open. 2019 Jan 15;9(1):e024963 - PubMed
  15. BMJ Open. 2017 Nov 3;7(11):e016030 - PubMed
  16. PLoS One. 2014 Jan 28;9(1):e86405 - PubMed
  17. Value Health. 2019 Sep;22(9):1026-1032 - PubMed
  18. Eur J Vasc Endovasc Surg. 1995 Feb;9(2):181-8 - PubMed
  19. Ann Acad Med Singapore. 2015 Dec;44(12):567-70 - PubMed
  20. Diabet Med. 1993 Aug-Sep;10(7):676-9 - PubMed
  21. Eur J Vasc Endovasc Surg. 1996 Oct;12(3):359-62 - PubMed
  22. J Vasc Surg. 2012 Oct;56(4):1015-24.e1 - PubMed
  23. J Med Econ. 2013;16(6):820-7 - PubMed
  24. Lancet. 2013 Oct 19;382(9901):1329-40 - PubMed
  25. Prev Chronic Dis. 2011 Nov;8(6):A141 - PubMed
  26. Diabet Med. 2011 Oct;28(10):1144-53 - PubMed
  27. J Diabetes Complications. 2008 Sep-Oct;22(5):317-24 - PubMed

Publication Types